125 related articles for article (PubMed ID: 19823085)
1. Targeting bone morphogenetic protein signaling on renal and vascular diseases.
Maciel TT; Kempf H; Campos AH
Curr Opin Nephrol Hypertens; 2010 Jan; 19(1):26-31. PubMed ID: 19823085
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic proteins in vascular calcification.
Hruska KA; Mathew S; Saab G
Circ Res; 2005 Jul; 97(2):105-14. PubMed ID: 16037577
[TBL] [Abstract][Full Text] [Related]
3. BMP signaling in vascular diseases.
Cai J; Pardali E; Sánchez-Duffhues G; ten Dijke P
FEBS Lett; 2012 Jul; 586(14):1993-2002. PubMed ID: 22710160
[TBL] [Abstract][Full Text] [Related]
4. [BMP in the kidney: signaling, function and pathophysiological significance].
Hanai J
Clin Calcium; 2007 May; 17(5):704-10. PubMed ID: 17470999
[TBL] [Abstract][Full Text] [Related]
5. Paracrine osteogenic signals via bone morphogenetic protein-2 accelerate the atherosclerotic intimal calcification in vivo.
Nakagawa Y; Ikeda K; Akakabe Y; Koide M; Uraoka M; Yutaka KT; Kurimoto-Nakano R; Takahashi T; Matoba S; Yamada H; Okigaki M; Matsubara H
Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):1908-15. PubMed ID: 20651281
[TBL] [Abstract][Full Text] [Related]
6. Bmp modulators in kidney disease.
Nakamura J; Yanagita M
Discov Med; 2012 Jan; 13(68):57-63. PubMed ID: 22284784
[TBL] [Abstract][Full Text] [Related]
7. High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells.
Chen NX; Duan D; O'Neill KD; Moe SM
Nephrol Dial Transplant; 2006 Dec; 21(12):3435-42. PubMed ID: 17005530
[TBL] [Abstract][Full Text] [Related]
8. [Vascular calcification: types and mechanisms].
Valdivielso JM
Nefrologia; 2011; 31(2):142-7. PubMed ID: 21461006
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.
Teichert-Kuliszewska K; Kutryk MJ; Kuliszewski MA; Karoubi G; Courtman DW; Zucco L; Granton J; Stewart DJ
Circ Res; 2006 Feb; 98(2):209-17. PubMed ID: 16357305
[TBL] [Abstract][Full Text] [Related]
10. Vascular calcification in patients with renal failure: culprit or innocent bystander?
Dellegrottaglie S; Saran R; Rajagopalan S
Cardiol Clin; 2005 Aug; 23(3):373-84. PubMed ID: 16084285
[TBL] [Abstract][Full Text] [Related]
11. [Vascular calcification].
Shioi A
Clin Calcium; 2004 Jun; 14(6):38-41. PubMed ID: 15577052
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic protein 7: a novel treatment for chronic renal and bone disease.
Li T; Surendran K; Zawaideh MA; Mathew S; Hruska KA
Curr Opin Nephrol Hypertens; 2004 Jul; 13(4):417-22. PubMed ID: 15199292
[TBL] [Abstract][Full Text] [Related]
13. Expression of gremlin, a bone morphogenetic protein antagonist,is associated with vascular calcification in uraemia.
Jara A; Chacón C; Burgos ME; Droguett A; Valdivieso A; Ortiz M; Troncoso P; Mezzano S
Nephrol Dial Transplant; 2009 Apr; 24(4):1121-9. PubMed ID: 19028757
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic protein signaling in the developing kidney: present and future.
Cain JE; Hartwig S; Bertram JF; Rosenblum ND
Differentiation; 2008 Oct; 76(8):831-42. PubMed ID: 18331343
[TBL] [Abstract][Full Text] [Related]
15. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension.
Yang X; Long L; Southwood M; Rudarakanchana N; Upton PD; Jeffery TK; Atkinson C; Chen H; Trembath RC; Morrell NW
Circ Res; 2005 May; 96(10):1053-63. PubMed ID: 15845886
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein (BMP) family, SMAD signaling and Id helix-loop-helix proteins in the vasculature: the continuous mystery of BMPs pleotropic effects.
Abe J
J Mol Cell Cardiol; 2006 Jul; 41(1):4-7. PubMed ID: 16762360
[No Abstract] [Full Text] [Related]
17. [Is there any role predictable for bone morphogenetic protein-7 in nephrology?].
Mazzaferro S
G Ital Nefrol; 2006; 23(2):129-37. PubMed ID: 16710818
[TBL] [Abstract][Full Text] [Related]
18. Calcium-sensing receptor as a potential modulator of vascular calcification in chronic kidney disease.
Caudrillier A; Mentaverri R; Brazier M; Kamel S; Massy ZA
J Nephrol; 2010; 23(1):17-22. PubMed ID: 20091482
[TBL] [Abstract][Full Text] [Related]
19. Antagonists of bone morphogenetic proteins in kidney disease.
Yanagita M
Curr Opin Investig Drugs; 2010 Mar; 11(3):315-22. PubMed ID: 20178045
[TBL] [Abstract][Full Text] [Related]
20. The role of BMPs in endothelial cell function and dysfunction.
Dyer LA; Pi X; Patterson C
Trends Endocrinol Metab; 2014 Sep; 25(9):472-80. PubMed ID: 24908616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
